SHORR ROBERT G L

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$291,225.25

Insider Activity of SHORR ROBERT G L

The largest sale of all time was on 2011-10-04 and amounted to 210000 shares of Brainstorm Cell Therapeutics Inc. for $65,709.

Biography of SHORR ROBERT G L

No biography is available at this moment.

2015-12-16SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
10,800
0.0576%
$2.71$29,268-13.41%
2015-12-11SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
5,300
0.0289%
$2.56$13,568-6.27%
2015-12-10SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
5,500
0.0298%
$2.71$14,905-12.13%
2011-12-05SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
98,333
0.0775%
$0.26$25,144-11.33%
2011-11-28SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
10,000
0.0083%
$0.27$2,700-12.86%
2011-10-05SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
95,000
0.0801%
$0.30$28,852-18.68%
2011-10-04SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
210,000
0.1823%
$0.31$65,709-18.33%
2009-10-26SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
80,000
0.1233%
$0.31$24,880-22.72%
2009-10-22SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
40,000
0.0592%
$0.34$13,400-31.05%
2009-10-21SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
50,000
0.0818%
$0.29$14,500-9.14%
2009-10-20SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
100,000
0.1579%
$0.28$28,000-8.78%
2009-10-19SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
100,000
0.1551%
$0.28$27,500-10.35%
2009-10-16SaleBrainstorm Cell Therapeutics Inc.
BCLI
director
10,000
0.0164%
$0.28$2,800-6.48%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.